In an effort to be more visible to the public, the FDA now publishes its own 'transparency blog". This post deals with their role in regulating orphan drugs in service of the 7000+ rare diseases.
Posted by Bruce Lehr June 22nd 2010.
TrackBack URL for this entry:
Listed below are links to weblogs that reference FDA Comments on Its Role in Rare Diseases & Orphan Drugs:
The comments to this entry are closed.